Bab Bio Ventures Nv - Net Worth and Insider Trading

Bab Bio Ventures Nv Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bab Bio Ventures Nv owns 1 companies in total, including Acorda Therapeutics Inc (ACORQ) .

Click here to see the complete history of Bab Bio Ventures Nv’s form 4 insider trades.

Insider Ownership Summary of Bab Bio Ventures Nv

Ticker Comapny Transaction Date Type of Owner
ACORQ Acorda Therapeutics Inc 2003-12-17 10 percent owner

Bab Bio Ventures Nv Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Bab Bio Ventures Nv Ownership Network

Ownership Network List of Bab Bio Ventures Nv

No Data

Ownership Network Relation of Bab Bio Ventures Nv

Insider Network Chart

Bab Bio Ventures Nv Owned Company Details

What does Acorda Therapeutics Inc do?

Who are the key executives at Acorda Therapeutics Inc?

Bab Bio Ventures Nv is the 10 percent owner of Acorda Therapeutics Inc. Other key executives at Acorda Therapeutics Inc include CEO and President Ron Cohen , Chief Financial Officer Michael A Gesser , and General Counsel Neil S. Belloff .

Acorda Therapeutics Inc (ACORQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acorda Therapeutics Inc (ACORQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acorda Therapeutics Inc (ACORQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acorda Therapeutics Inc (ACORQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acorda Therapeutics Inc Insider Transactions

No Available Data

Bab Bio Ventures Nv Mailing Address

Above is the net worth, insider trading, and ownership report for Bab Bio Ventures Nv. You might contact Bab Bio Ventures Nv via mailing address: 111 Huntington Ave, 31st Fl, Boston Ma 02199.

Discussions on Bab Bio Ventures Nv

No discussions yet.